Facelift After GLP-1 Weight Loss: Dr. Daniel Gould Featured in The Daily Beast

Beverly Hills plastic surgeon Dr. Daniel Gould, MD, PhD was recently featured in The Daily Beast discussing the growing impact of significant GLP-1 weight loss on facial aging and how surgical rejuvenation can address loose skin, volume loss, and changes to the face and neck.

The article follows one of Dr. Gould’s patients, Leah, who lost 80 pounds over two years while taking a GLP-1 medication. Following her weight loss, she began to notice significant skin laxity, particularly around her face and neck. Dr. Gould explains that he is increasingly seeing similar concerns among younger patients who have lost substantial amounts of weight with medications such as Ozempic, Wegovy, and Mounjaro.

According to Dr. Gould, the effects of significant weight loss extend beyond a reduction in facial volume. Skin quality and tissue support can also change, creating laxity that may not be adequately addressed by simply replacing lost volume. Before considering surgery, Dr. Gould requires patients using GLP-1 medications to have maintained a stable weight for more than six months, helping ensure that their results can be planned around a weight they are likely to maintain.

For Leah, Dr. Gould developed a comprehensive surgical plan that included a deep-plane facelift, temporal lift, and neck lift. Rather than treating the neck as an isolated area, the procedures were designed to reposition interconnected facial tissues in a coordinated way and create a balanced, natural result.

Volume restoration was also an important part of the treatment. Dr. Gould performed fat transfer to restore facial volume as well as nano fat transfer to support skin quality. He even addressed volume loss in the upper earlobes, an area that can become thinner following significant weight loss. By considering these smaller anatomical changes alongside the face and neck, the goal was to create a result that felt cohesive rather than simply tighter.

The article also highlights the importance of patient selection and realistic expectations. Dr. Gould discusses screening patients before surgery and ensuring that the decision to undergo facial rejuvenation comes from a healthy understanding of what surgery can realistically achieve. As GLP-1 medications continue to transform weight management, his approach emphasizes stable weight, individualized treatment planning, and preserving the patient’s identity while addressing the structural effects of significant weight loss.

Read the full article in The Daily Beast:
https://thelooker.thedailybeast.com/woman-gets-stunning-facelift-after-80-lb-weight-loss-caused-ozempic-face/